Clinical Trials
20 trialsNCT03823534 2026-04-22
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
St. Louis University
Phase 3 Recruiting
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT04475029 2023-09-13
METAMORF
University of Aarhus
Phase NA Completed
NCT01318161 2021-02-16
EPICOL
Örebro University, Sweden
Phase 3 Terminated
NCT00726830 2020-09-24
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
M.D. Anderson Cancer Center
Phase NA Terminated
NCT04292990 2020-07-29
Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients
Jiangmen Central Hospital
Phase 4 Unknown
NCT00003687 2020-04-03
Treatment for Chronic Pain in Patients With Advanced Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT03324815 2017-10-30
Methadone Associated With Morphine for Cancer Pain
Federal University of São Paulo
Phase NA Unknown
NCT02044302 2017-04-10
A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
Yale University
Phase 2 Terminated
NCT00446069 2016-08-29
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
Egalet Ltd
Phase 2 Completed
NCT00558870 2016-04-05
Role of Methadone As Co-Opioid Analgesic
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT00003000 2015-10-14
Morphine for the Treatment of Pain in Patients With Breast Cancer
Roswell Park Cancer Institute
Completed
NCT00660348 2014-10-08
Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Terminated
NCT00378937 2013-08-02
Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
National Cancer Institute (NCI)
Phase 4 Completed
NCT00020618 2013-07-18
Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain
National Cancer Institute (NCI)
Phase 2 Completed
NCT00125684 2012-01-19
Bioavailability and Effectiveness of Transdermally Administered Morphine
AHS Cancer Control Alberta
Phase 1 Completed
NCT00410540 2010-04-27
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Alza Corporation, DE, USA
Phase 3 Completed
NCT00822614 2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3 Unknown